Tenderwize
Back to tender search

Ibuprofen 400 mg and 600 mg (prescription, non-retarded)

AOK Sachsen-Anhalt - Die Gesundheitskasse·Magdeburg, Germany·Deadline Mar 30, 2027 · 170 days left·Open·Supplies
Structured notice only
Original notice title

Germany – Pharmaceutical products – Arzneimittel mit dem Wirkstoff Ibuprofen (ATC: M01AE01 - verschreibungspflichtig, in nicht retardierter Darreichungsform mit den Wirkstärken 400mg und 600mg)

55/100

Opportunity Score

Needs reviewLow complexity
SuppliesOpen
Why this score?

Opportunity

55 / 100

Complexity

20 / 100

Risk factors

No volume commitment; the agreement only provides a framework for discounts but does not guarantee any sales.

This is not a public procurement under EU law. Legal protection mechanisms (e.g., suspension periods) are only cited vo...

Deep Portfolio Analysis

Deep Company Fit Analysis

Uses:

  • Description
  • Industries & Services
  • Capabilities
  • Market & Experience
  • Certifications

Tender facts

Contracting authority
AOK Sachsen-Anhalt - Die Gesundheitskasse
Country
Germany
CPV
33600000 - Pharmaceutical products
Deadline
Mar 30, 2027

Overview

Moderate opportunity

Key Facts

  • Supplies contract
  • 1 lot
  • Duration 2 YEAR
  • Supply of Ibuprofen 400 mg and 600 mg prescription-only non-retarded finished medicinal products under non-exclusive discount agreements
  • Contracting with the statutory health insurance fund AOK Sachsen-Anhalt
Show full summary

This is a non-exclusive open-house model for discount agreements under German social law (§130a SGB V) for Ibuprofen 400mg and 600mg (prescription, non-retarded). Any eligible pharmaceutical company can join at any time until 31 March 2027, with contracts starting from 1 June 2025 and lasting maximum 24 months (until 31 May 2027). The publication is voluntary for transparency; it is not a public procurement under EU law. No estimated value is stated, and no award criteria weights are provided. Submission is mainly by post, but electronically signed PDFs via email are also accepted.

Risks

No volume commitment; the agreement only provides a framework for discounts but does not guarantee any sales.

This is not a public procurement under EU law. Legal protection mechanisms (e.g., suspension periods) are only cited vo...

Analysis may be incomplete

Only part of the procurement documentation was analyzed. Additional eligibility requirements, certificates, or submission documents may exist in the remaining tender documentation.

Key Requirements

Technical

  • No exclusivity; each qualifying company gets a contract on identical terms
  • Contract period: max 24 months, ends 31 May 2027, starting no earlier than 1 June 2025

Eligibility

  • Eligible: any pharmaceutical company or consortium that meets participation requirements under §130a SGB V

Requirements may be incomplete.

Award Criteria

Lot 1

No award criteria specified; all eligible companies are accepted without competition.

Buyer

Location

Magdeburg, DEU

Buyer profile

Open profile

Identifier

DE258393558

Activity

Health

Lots (1)

LOT-0001

Ibuprofen 400 mg and 600 mg (prescription, non-retarded)

Non-exclusive discount agreements for Ibuprofen finished medicinal products with active substance Ibuprofen (ATC M01AE01) in strengths 400mg and 600mg, prescription-only, non-retarded form. Open to all qualifying pharmaceutical companies. No exclusivity. Contract duration max 24 months from earliest start 01.06.2025 to 31.05.2027.

SuppliesEU fundedElectronic submission

Location

DEE03, Germany

Duration

2 YEAR

Category

Pharmaceutical products

Award Criteria

No award criteria specified; all eligible companies are accepted without competition.

Deadline

Deadline Mar 30, 2027

Procurement Details

Publication date
09 Apr 2025
Languages
German

Reference metadata

Legal basis
32014L0024

Reference IDs

Tender ID
233889-2025

Documents (1)

Similar tenders